The pharmaceutical industry faces significant challenges in developing novel therapies. Timelines are often extended, costs are increasing and success rates remain inadequate. Integrated discovery solutions, however, offer a promising pathway to overcome these hurdles. By linking various stages of the drug development cycle, from target identificat